KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for Biogen (BIIB) over the last 3 years, with Q4 2025 value amounting to $75.4 million.

  • Biogen's Amortizatization of Intangibles rose 6792.87% to $75.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $240.8 million, marking a year-over-year increase of 469.57%. This contributed to the annual value of $240.8 million for FY2025, which is 469.57% up from last year.
  • Per Biogen's latest filing, its Amortizatization of Intangibles stood at $75.4 million for Q4 2025, which was up 6792.87% from $61.5 million recorded in Q3 2025.
  • Biogen's Amortizatization of Intangibles' 5-year high stood at $90.1 million during Q2 2024, with a 5-year trough of $31.5 million in Q4 2023.
  • For the 3-year period, Biogen's Amortizatization of Intangibles averaged around $55.8 million, with its median value being $51.4 million (2025).
  • Examining YoY changes over the last 5 years, Biogen's Amortizatization of Intangibles showed a top increase of 6792.87% in 2025 and a maximum decrease of 4173.14% in 2025.
  • Over the past 3 years, Biogen's Amortizatization of Intangibles (Quarter) stood at $31.5 million in 2023, then skyrocketed by 42.54% to $44.9 million in 2024, then soared by 67.93% to $75.4 million in 2025.
  • Its last three reported values are $75.4 million in Q4 2025, $61.5 million for Q3 2025, and $52.5 million during Q2 2025.